Price to Earnings of Incyte

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Earnings analysis of Incyte


 Price 63.59  USD
 Earnings per share -1.38  USD
 Capitalization (mn) 11,126  USD
 Net income (mn) -293  USD
 P/E ratio -46.20
 Incyte dividend
 Incyte Price to book Value
 Incyte Price to Cash-Flow
 Incyte Return on Equity

Incyte is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. Incyte headquarters are in USA, where the firm is listed.

At the time of this analysis, Incyte stocks were trading at a price of 63.59 USD after falling slightly their price a -1.00% last month.

According to the graph below, where Price to earnings comparison chart is displayed, Incyte, has a very negative P/E ratio of -46.20, amount in contrast with the average P/E of the market and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This negative P/E of Incyte means the company is making a huge loss (really negative net profit), so it is a compulsory for the firm to change their decissions in order to solve the problem. More Incyte financial data can be accessed on the link.

Finally, you could compare Incyte P/E with other Pharmaceuticals and Biotechnology companies or firms from USA.

Incyte price to earnings

Next companies

Indah Kiat Pulp & Paper. India. Basic Materials.

Indiabulls Housing F. India. Financials.

Indian Oil. India. Oil and Gas.

Inditex. Spain. Consumer Services.

Indo Tambangraya Meg. Indonesia. Basic Materials.

Indocemt Tunggal Pra. Indonesia. Industrials.

Previous companies

Incitec Pivot Ltd. Australia. Basic Materials.

Inchcape. UK. Consumer Services.

IMS Health Holdings. USA. Technology.

Imperial Tobacco Gp. UK. Consumer Goods.

Imperial Pacific Int. Hong-Kong. Consumer Goods.

Imperial Oil. Canada. Oil and Gas.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.